title: [Enterosorption in chronic enterocolitis].
abstract: Polyfepan, a sorbent, included in the complex of therapeutic measures for the patients with exacerbations of chronic enterocolitis, has considerably reduced the terms necessary to arrest the major symptoms of the condition vs. the reference group. The effect was the most manifest when the sorbent was combined with polyenzyme drugs. Laboratory tests and rat experiments have helped validate polyfepan action as the agent binding microorganisms and their toxins on its surface and fixing the enzyme vector at the site of the pathologic process.
authors.forename: V V
authors.initials: VV
authors.lastname: Shchedrunov
authors.forename: A V
authors.initials: AV
authors.lastname: Solomennikov
authors.forename: M T
authors.initials: MT
authors.lastname: Ismailov
authors.forename: I M
authors.initials: IM
authors.lastname: Zhuravskaia
authors.forename: E N
authors.initials: EN
authors.lastname: Lapteva
authors.forename: N A
authors.initials: NA
authors.lastname: Beliakov
mesh_terms: D000327:Adsorption; D000328:Adult; D000992:Antitoxins; D001424:Bacterial Infections / Q000188:drug therapy*; D002908:Chronic Disease; D004760:Enterocolitis / Q000188:drug therapy*; D004768:Enterotoxins / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008031:Lignin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000992:Antitoxins; D004768:Enterotoxins; C056995:polyfepan; D008031:Lignin
vernacular_title: Enterosorbtsiia pri khronicheskom énterokolite.